GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Autobio Diagnostics Co Ltd (SHSE:603658) » Definitions » Margin of Safety % (DCF FCF Based)

Autobio Diagnostics Co (SHSE:603658) Margin of Safety % (DCF FCF Based) : -264.93% (As of Jun. 06, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Autobio Diagnostics Co Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

As of today (2024-06-06), Autobio Diagnostics Co's Predictability Rank is 3.5-Stars. Autobio Diagnostics Co's intrinsic value calculated from the Discounted FCF model is ¥70.97 and current share price is ¥49.85. Consequently,

Autobio Diagnostics Co's Margin of Safety % (DCF FCF Based) using Discounted FCF model is -264.93%.

Competitive Comparison of Autobio Diagnostics Co's Margin of Safety % (DCF FCF Based)

For the Medical Devices subindustry, Autobio Diagnostics Co's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Autobio Diagnostics Co's Margin of Safety % (DCF FCF Based) Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Autobio Diagnostics Co's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Autobio Diagnostics Co's Margin of Safety % (DCF FCF Based) falls into.


Autobio Diagnostics Co Margin of Safety % (DCF FCF Based) Calculation

Autobio Diagnostics Co's Margin of Safety % (DCF FCF Based) for today is calculated as

Margin of Safety % (DCF FCF Based)=(Intrinsic Value: DCF (FCF Based)-Current Price)/Intrinsic Value: DCF (FCF Based)
=(13.66-49.85)/13.66
=-264.93 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted FCF model with default parameters. The calculation method is the same as Discounted Earnings model except free cash flow are used in the calculation instead of earnings per share.

Autobio Diagnostics Co Margin of Safety % (DCF FCF Based) Related Terms

Thank you for viewing the detailed overview of Autobio Diagnostics Co's Margin of Safety % (DCF FCF Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

Autobio Diagnostics Co (SHSE:603658) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Autobio Diagnostics Co Ltd (SHSE:603658) » Definitions » Margin of Safety % (DCF FCF Based)
Comparable Companies
SHSE:688617 SZSE:300633 SZSE:300003 SZSE:300529 SHSE:688198 SHSE:688114 SZSE:300298 SHSE:688161 SZSE:002901 SZSE:301363 ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
N/A
Address
No.199, 15th Avenue, National Economic and Technological Development Area, Zhengzhou, CHN, 450016
Website
http://www.autobio.com.cn
Autobio Diagnostics Co Ltd is a clinical diagnostics company in China. It specializes in research and development, production, marketing and service of clinical diagnostic products, including immunoassay, microbiology and biochemical products. It focuses on the common development of both reagents and instruments. Reagents products include immunoassay, biochemistry, microbiology, and IVD subdivision areas, and instruments include both full automation and semi-automation instruments and systems. Geographically it holds a strong distribution network with thousands of distributors in the Chinese market.
Executives
Miao Yong Jun Director

Autobio Diagnostics Co (SHSE:603658) Headlines

No Headlines